Sextant Systematic Biopsy Versus Extended 12-Core Systematic Biopsy in Combined Biopsy for Prostate Cancer.
Jae Hoon ChungWan SongMinyong KangHyun Hwan SungHwang Gyun JeonByung Chang JeongSeong Il SeoSeong Soo JeonHyun Moo LeeByung Kwan ParkPublished in: Journal of Korean medical science (2024)
During combined biopsy for prostate cancer in patients with PI-RADS 3 or 5, sextant systematic biopsy should be recommended over extended 12-core systematic biopsy when an effective targeted biopsy is performed.